Jobs / United States / Modernatx INC
Senior Manager, Study Management & Outsourcing (Canada)
Modernatx INC · 🇺🇸 Location unlisted
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 53 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 17 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Modernatx INC paid sponsored hires in similar roles3 certified filings for “Sr. Manager, Pharmacovigilance Scientist” (Medical Scientists, Except Epidemiologists) in MA: $88k–$131k, median $107k. Most were filed at wage level II (67%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 1 day agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Modernatx INC
The US Department of Labor certified 53 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 17 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Modernatx INC →
About the role
The Role: Joining Moderna means advancing mRNA science to transform medicine. Work with exceptional global teams on a broad pipeline and build a career that makes a real difference for patients. Moderna is expanding its impact across Canada, with commercial operations in Toronto and a strategic manufacturing partnership in Laval. In Toronto, we bring our mRNA medicines to patients nationwide. In Laval, our mRNA vaccine facility will strengthen pandemic preparedness and rapid access to vaccines. Join us to help advance biotechnology and support Canada’s leadership in global health. This is an opportunity to lead sponsor-side oversight of critical nonclinical studies that directly influence the advancement of Moderna's innovative mRNA medicines. As the Canada-based study owner, you will provide scientific, technical, and operational leadership across outsourced GLP and non-GLP studies, ensuring every stage—from protocol development through final report—delivers high-quality data that enables strategic decision-making and supports global regulatory submissions. Working across a highly matrixed environment, you will partner with multidisciplinary scientific teams and external Contract Research Organizations (CROs) to deliver complex development programs. Your expertise in study management, scientific oversight, compliance, and stakeholder leadership will ensure studies remain scientifically rigorous, operationally efficient, inspection-ready, and aligned with Moderna's ambitious development goals. You'll also have opportunities to work alongside teams leveraging advanced digital technologies and Generative AI-enabled tools to enhance study planning, documentation, data review, and operational excellence. Here's What You'll Do: • Lead sponsor-side oversight of GLP and non-GLP nonclinical studies from protocol development through final report, providing scientific and technical leadership across study rationale, protocol design, endpoint selection, data review, interpretation, and reporting to support critical development and regulatory decisions. • Serve as the study owner with accountability for study quality, timelines, budgets, deliverables, operational execution, and overall study outcomes. • Ensure all studies are conducted in compliance with GLP (where applicable), global regulatory expectations, and inspection-ready standards throughout the study lifecycle. • Provide Canada-based leadership and scientific guidance to Study Monitors, promoting consistency, quality, and operational excellence. • Act as the primary sponsor contact for Canada-based CROs, building strong collaborative partnerships while ensuring clear communication, documentation of decisions, and appropriate oversight of work performed on Moderna's behalf. • Develop, negotiate, and review Statements of Work (SOWs), ensuring scope, timelines, budgets, deliverables, change controls, and study objectives remain aligned with program priorities. • Monitor CRO performance, proactively identify operational or scientific risks, drive issue resolution, and escalate challenges appropriately to maintain study progress. • Lead protocol development, protocol amendments, deviation management, scientific review, and approval of final study reports. • Oversee study conduct through continuous review of emerging data, protocol deviations, scientific findings, unexpected observations, inconclusive results, and recommendations for additional analyses or study modifications when appropriate. • Conduct Canada-based site visits and observe CRO activities as required to ensure effective sponsor oversight. • Coordinate cross-functional scientific review of protocols, data packages, interim analyses, and final reports. • Drive alignment across Toxicology, Drug Metabolism & Pharm